REFERENCES

1. Abbott JA, Francklyn CS, Robey-Bond SM. Transfer RNA and human disease. Front Genet 2014;5:158.

2. Ognjenović J, Simonović M. Human aminoacyl-tRNA synthetases in diseases of the nervous system. RNA Biol 2018;15:623-34.

3. Antonellis A, Green ED. The role of aminoacyl-tRNA synthetases in genetic diseases. Annu Rev Genomics Hum Genet 2008;9:87-107.

4. Taft RJ, Vanderver A, Leventer RJ, et al. Mutations in DARS cause hypomyelination with brain stem and spinal cord involvement and leg spasticity. Am J Hum Genet 2013;92:774-80.

5. Wolf NI, Toro C, Kister I, et al. DARS-associated leukoencephalopathy can mimic a steroid-responsive neuroinflammatory disorder. Neurology 2015;84:226-30.

6. Muthiah A, Housley GD, Klugmann M, Fröhlich D. The leukodystrophies HBSL and LBSL-correlates and distinctions. Front Cell Neurosci 2020;14:626610.

7. Scheper GC, van der Klok T, van Andel RJ, et al. Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nat Genet 2007;39:534-9.

8. Dogan SA, Pujol C, Maiti P, et al. Tissue-specific loss of DARS2 activates stress responses independently of respiratory chain deficiency in the heart. Cell Metab 2014;19:458-69.

9. Fröhlich D, Suchowerska AK, Spencer ZH, et al. In vivo characterization of the aspartyl-tRNA synthetase DARS: homing in on the leukodystrophy HBSL. Neurobiol Dis 2017;97:24-35.

10. Fröhlich D, Mendes MI, Kueh AJ, et al. A hypomorphic Dars1^D367Y model recapitulates key aspects of the leukodystrophy HBSL. Front Cell Neurosci 2020;14:625879.

11. Klugmann M, Kalotay E, Delerue F, et al. Developmental delay and late onset HBSL pathology in hypomorphic Dars1^M256L mice. Neurochem Res 2022;47:1972-84.

12. Fröhlich D, Suchowerska AK, Voss C, et al. Expression pattern of the aspartyl-tRNA synthetase DARS in the human brain. Front Mol Neurosci 2018;11:81.

13. Lipman NS, Jackson LR, Trudel LJ, Weis-Garcia F. Monoclonal versus polyclonal antibodies: distinguishing characteristics, applications, and information resources. ILAR J 2005;46:258-68.

14. Howat WJ, Lewis A, Jones P, et al. Antibody validation of immunohistochemistry for biomarker discovery: recommendations of a consortium of academic and pharmaceutical based histopathology researchers. Methods 2014;70:34-8.